To the full analysis
Healthpeak Properties stock: growth
DOCHealthpeak Properties reported $2.82B in revenue for fiscal 2025, up 4.5% on the prior year, up 11.4% a year on average over up to five years.
Daily figure as of 12 Nov 2026
Revenue (Annual rate)
3.7%
per year from 2011 to 2025, per share −0.3%
Earnings (Annual rate)
−13.4%
per year from 2011 to 2025, per share −16.7%
Free cash flow (Annual rate)
4.6%
per year from 2011 to 2025, per share 0.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2011 | |
|---|---|---|---|
| Revenue | 11.4% | 3.8% | 3.7% |
| Revenue per share | 5.5% | −0.3% | −0.3% |
| Earnings | −29.6% | no data | −13.4% |
| Earnings per share | −33.5% | no data | −16.7% |
| Free cash flow | 10.5% | 0.2% | 4.6% |
| Free cash flow per share | 4.7% | −3.8% | 0.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2011 | $1.69B | $538.89M | $671.26M |
| 2012 | $1.88B | $832.54M | $1.03B |
| 2013 | $2.1B | $970.84M | $1.15B |
| 2014 | $1.64B | $922.23M | $1.25B |
| 2015 | $1.94B | −$559.24M | $1.22B |
| 2016 | $2.13B | $627.75M | $1.21B |
| 2017 | $1.85B | $414.17M | $847.04M |
| 2018 | $1.19B | $1.06B | $848.71M |
| 2019 | $1.24B | $45.53M | $846.07M |
| 2020 | $1.64B | $413.56M | $758.43M |
| 2021 | $1.9B | $505.54M | $795.25M |
| 2022 | $2.06B | $500.45M | $900.26M |
| 2023 | $2.18B | $306.01M | $956.24M |
| 2024 | $2.7B | $243.14M | $1.07B |
| 2025 | $2.82B | $71.35M | $1.25B |
Revenue by segment
How Healthpeak Properties, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Outpatient Medical Buildings$1.3B45%
- Lab$860.0M30%
- Senior Housing$604.0M21%
- Other$85.0M3%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Outpatient Medical Buildings | $1.27B | 45.1% |
| Lab | $860.02M | 30.5% |
| Senior Housing | $603.99M | 21.4% |
| Other | $85M | 3% |
| Total revenue | $2.82B | 100% |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 21 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.